Tenaya Therapeutics (NASDAQ:TNYA) just reported results for the first quarter of 2024.
- Tenaya Therapeutics reported earnings per share of -40 cents. This was above the analyst estimate for EPS of -42 cents.
- The company did not report any revenue for the quarter.